Alterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemia

Simple item page
dc.contributor.authorFisher-Wellman, Kelsey H.
dc.contributor.authorHagen, James T.
dc.contributor.authorNelson, Margaret A. M.
dc.contributor.authorMcLaughlin, Kelsey L.
dc.contributor.authorCoalson, Hannah S.
dc.contributor.authorKassai, Miki
dc.contributor.authorKao, Li-Pin
dc.contributor.authorCabot, Myles C.
dc.date.accessioned2022-11-21T18:23:13Z
dc.date.available2022-11-21T18:23:13Z
dc.date.issued2022-01
dc.identifier.doi10.1096/fj.202101194RRR
dc.identifier.issn0892-6638
dc.identifier.urihttp://hdl.handle.net/10342/11776
dc.language.isoen_USen_US
dc.subjectacute myeloid leukemiaen_US
dc.subjectchemotherapy resistanceen_US
dc.subjectmitochondrial bioenergeticsen_US
dc.titleAlterations in Sphingolipid Composition and Mitochondrial Bioenergetics Represent Synergistic Therapeutic Vulnerabilities Linked to Multidrug Resistance in Leukemiaen_US
dc.typeArticleen_US
ecu.journal.issue1en_US
ecu.journal.nameFASEB Journalen_US
ecu.journal.volume36en_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
FisherWellmanAlterationsinSphingolipidCompositionandMitochondrialBioenergetics.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Physiology